- Home
- DXCM vs CNC Comparison
DXCM vs CNC Comparison
Compare DXCM & CNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DXCM
- CNC
- Stock Information
- Founded
- DXCM 1999
- CNC 1984
- Country
- DXCM United States
- CNC United States
- Employees
- DXCM N/A
- CNC N/A
- Industry
- DXCM Medical/Dental Instruments
- CNC Medical Specialities
- Sector
- DXCM Health Care
- CNC Health Care
- Exchange
- DXCM Nasdaq
- CNC Nasdaq
- Market Cap
- DXCM 27.7B
- CNC 31.7B
- IPO Year
- DXCM 2005
- CNC 2001
- Fundamental
- Price
- DXCM $68.57
- CNC $60.70
- Analyst Decision
- DXCM Strong Buy
- CNC Buy
- Analyst Count
- DXCM 18
- CNC 15
- Target Price
- DXCM $99.00
- CNC $80.64
- AVG Volume (30 Days)
- DXCM 4.9M
- CNC 4.7M
- Earning Date
- DXCM 05-01-2025
- CNC 04-25-2025
- Dividend Yield
- DXCM N/A
- CNC N/A
- EPS Growth
- DXCM 9.35
- CNC 27.48
- EPS
- DXCM 1.42
- CNC 6.31
- Revenue
- DXCM $4,033,000,000.00
- CNC $147,169,000,000.00
- Revenue This Year
- DXCM $16.39
- CNC $18.51
- Revenue Next Year
- DXCM $15.64
- CNC $2.38
- P/E Ratio
- DXCM $48.15
- CNC $9.62
- Revenue Growth
- DXCM 11.34
- CNC 4.08
- 52 Week Low
- DXCM $57.52
- CNC $55.03
- 52 Week High
- DXCM $139.24
- CNC $80.59
- Technical
- Relative Strength Index (RSI)
- DXCM 47.32
- CNC 48.04
- Support Level
- DXCM $64.99
- CNC $60.91
- Resistance Level
- DXCM $69.69
- CNC $63.15
- Average True Range (ATR)
- DXCM 3.47
- CNC 2.37
- MACD
- DXCM 1.00
- CNC -0.09
- Stochastic Oscillator
- DXCM 69.15
- CNC 28.93
About DXCM DexCom Inc.
Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.
About CNC Centene Corporation
Centene is a managed care organization that focuses on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of December 2024, mostly in Medicaid (about 60% of membership), the individual exchanges (about 20%), and Medicare (about 5%). The company also has a military contract and provides Medicare Part D pharmaceutical plans.